MADISON, Wis., Oct. 23, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2025, ended September 30, 2024, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on November 6, 2024.The conference call dial-in numbers are (833) 316-0563 (USA) or (412) 317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one wee ...

Core Insights - Accuray Incorporated has appointed Michael Murphy as Vice President, Corporate Controller, responsible for global accounting functions and reporting to CFO Ali Pervaiz [1][3] - Mr. Murphy has over 15 years of finance and accounting experience, previously serving at Duluth Holdings Inc. and holding roles at First Business Financial Services and Banco Popular North America [2] - The company emphasizes its commitment to innovation in radiation therapy to improve patient lives, highlighting its focus on collaboration and continuous improvement [4][5] Company Overview - Accuray is dedicated to advancing radiation therapy solutions for oncology and neuro-radiosurgery, aiming to meet diverse patient needs through innovative treatments [5] - The company is headquartered in Sunnyvale, California, and operates facilities worldwide, reinforcing its global presence in the healthcare sector [5]

MADISON, Wis., Oct. 15, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, effective as of today, Suzanne Winter has returned from her temporary medical leave and assumed her full duties as President and Chief Executive Officer. Sandeep Chalke, who has served as interim CEO during Ms. Winter's absence, will continue in his position as Senior Vice President and Chief Commercial Officer."On behalf of the entire Board of Directors, I am delighted Suzanne has resumed her role as CEO. We ap ...

Accuray is the first industry partner to open a facility at the Genolier Innovation Hub, created to provide opportunities for clinician-industry collaborations that can help accelerate improvements in patient careNew Accuray CyberComm™ tool was used to significantly reduce the CyberKnife® S7™ System's commissioning time and enable product training in Genolier to begin more quicklyMADISON, Wis., Sept. 30, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the initiation of CyberKnife® S ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33301 1240 Deming Way Madison, Wisconsin 53717 (Address of Principal Executive Offices) (Zip Code) Registrants' telepho ...

Accuray Incorporated (ARAY) is well-poised for growth in the coming quarters, courtesy of continued robust demand for its products. The optimism, led by robust international performance in fourth-quarter fiscal 2024 performance and potential in the Precision Treatment Planning System (TPS) and Radiosurgery Market, is expected to contribute further. However, reimbursement uncertainties and stiff competition are concerning.This Zacks Rank #3 (Hold) company has lost 23% in the year-to-date period against 9.2% ...

Accuray Incorporated (ARAY) recently announced that Japan-based Gifu Prefectural General Medical Center became the first hospital in the country to treat patients with surface-guided radiation therapy (SGRT) using its Radixact Radiation Delivery System and VitalHold (ARAY’s joint solution in partnership with C-Rad) package. The technology is expected to play a crucial role in the hospital's plan to expand patient access to high-precision radiation therapy treatments.Per Accuray, high-resolution cameras cont ...

MADISON, Wis., Sept. 3, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter will be taking a temporary medical leave of absence to receive care for a treatable form of cancer, effective immediately. Accuray Senior Vice President and Chief Commercial Officer Sandeep Chalke will serve as the interim CEO during Ms. Winter's absence. To ensure that Mr. Chalke and the organization have the necessary support, the company has formed an ...

Accuray Incorporated (ARAY) has announced that its innovative CT-guided helical radiotherapy system, Accuray Helix, has received the CE Mark, signaling its readiness for deployment in global markets. Designed to meet the needs of emerging regions where access to advanced cancer care is limited, the Accuray Helix system offers a cost-effective solution for delivering high-performance, precise radiation treatments. Radiotherapy is an essential part of cancer treatment, effective for both localized and advance ...

Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priorityDrives the next phase of company's strategic plan to expand its portfolio of helical radiation therapy delivery systemsMADISON, Wis., Aug. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has received CE Mark for Accuray Helix™, a CT-guided helical radiotherapy system designed to provide high-performance and high ...